Brind.

Analysis Compares CooperVision and QuidelOrtho Stock Metrics

1 report, 1 independent Updated Oct 11
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

A comparison was made between CooperVision and QuidelOrtho, examining several financial metrics including risk, profitability, and valuation. CooperVision has higher revenue and earnings compared to QuidelOrtho, while QuidelOrtho trades at a lower price-to-earnings ratio. CooperVision's stock price is 17% less volatile than the S&P 500, while QuidelOrtho's is 21% less volatile.

From dailypolitical.com

Why it matters

Some supportBrind's analysis of the reports

The comparison provides insight into the relative market positioning of the two healthcare companies, highlighting differences in valuation and risk profiles. High institutional ownership in QuidelOrtho, at 99.0%, contrasts with CooperVision's 24.4%.

From dailypolitical.com

Who's involved

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped